Ignite Creation Date:
2025-12-24 @ 10:12 PM
Ignite Modification Date:
2025-12-29 @ 8:02 PM
Study NCT ID:
NCT01103635
Status:
COMPLETED
Last Update Posted:
2020-04-07
First Post:
2010-04-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Tremelimumab and CP-870,893 in Patients With Metastatic Melanoma
Sponsor:
Abramson Cancer Center at Penn Medicine
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-02
Start Date Type:
ACTUAL
Primary Completion Date:
2016-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-05-02
Completion Date Type:
ACTUAL
First Submit Date:
2010-04-12
First Submit QC Date:
None
Study First Post Date:
2010-04-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-04-06
Last Update Post Date:
2020-04-07
Last Update Post Date Type:
ACTUAL